ExPEC4V

Last updated

ExPEC4V
Vaccine description
Target Escherichia coli [1]
Vaccine type conjugate [1]
Clinical data
Other namesExPEC4-V; ExPEC-4V; ExPECV4; ExPEC-V4; JNJ-63871860; JNJ63871860
Routes of
administration 		Intramuscular injection [1]

ExPEC4V, also known as JNJ-63871860, is a vaccine against urinary tract infections (UTIs) and Escherichia coli infection. [2] [1] [3] [4] It is an Escherichia coli polysaccharide conjugate vaccine. [2] [1] [4] The vaccine is administered by intramuscular injection. [1] It is being developed by GlycoVaxyn and Johnson & Johnson. [2] As of November 2023, ExPEC4V is in phase 2 clinical trials. [2] There is also a 10-valent form called ExPEC10V (VAC-52416; JNJ-69968054). [4] [5] In February 2025 Johnson & Johnson stopped the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo. [6]

See also

References

  1. 1 2 3 4 5 6 Huttner A, Gambillara V (October 2018). "The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coli". Clinical Microbiology and Infection. 24 (10): 1046–1050. doi:10.1016/j.cmi.2018.05.009. PMID   29803843.
  2. 1 2 3 4 "JNJ 63871860". AdisInsight. 5 November 2023. Retrieved 26 February 2025.
  3. ↑ Qiu L, Chirman D, Clark JR, Xing Y, Hernandez Santos H, Vaughan EE, et al. (2024). "Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges". Gut Microbes. 16 (1): 2359691. doi:10.1080/19490976.2024.2359691. PMC   11152113 . PMID   38825856.
  4. 1 2 3 Doiron RC, Cotechini T, Nickel JC (June 2024). "It's Time to Embrace Vaccination as We Enter the Postantibiotic Era of Recurrent Urinary Tract Infection Management". The Journal of Urology. 211 (6): 797–799. doi:10.1097/JU.0000000000003969. PMID   38704743.
  5. ↑ "VAC 52416". AdisInsight. 28 April 2023. Retrieved 26 February 2025.
  6. ↑ "J&J stops Phase III trial of Sanofi's E. Coli vaccine citing 'disappointing' results". Clinical Trials Arena. February 13, 2025.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.